Small liposomes accelerate the fibrillation of amyloid β (1-40)

Mayu S Terakawa1, Hisashi Yagi1, Masayuki Adachi1

  • 1From the Institute for Protein Research, Osaka University, Yamadaoka 3-2, Suita, Osaka 565-0871, Japan.

Insights

Smaller liposomes accelerate amyloid β (Aβ) fibrillation by increasing membrane curvature, promoting Aβ monomer binding and nucleation, which is key in Alzheimer disease pathology.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Materials Science

Background:

  • Amyloid β (Aβ) peptide deposition is a hallmark of Alzheimer disease.
  • Aβ interactions with membranes, including phosphatidylcholine, can cause deformation and fibrillation.
  • The role of membrane curvature in Aβ binding and fibrillation is not well understood.

Purpose of the Study:

  • To investigate the relationship between membrane curvature, Aβ binding, and amyloid fibrillation.
  • To elucidate the influence of liposome size-dependent membrane curvature on Aβ-(1-40) fibrillation.

Main Methods:

  • Studied amyloid fibrillation of Aβ-(1-40) using liposomes of varying sizes (50 nm and larger).
  • Utilized liposomes composed of 1,2-dioleoyl-sn-glycero-3-phosphocholine to exclude electrostatic effects.
  • Monitored fibril morphology using total internal reflection fluorescence microscopy, atomic force microscopy, and transmission electron microscopy.

Main Results:

  • Smaller liposomes (≤50 nm) significantly accelerated Aβ nucleation, shortening fibrillation lag time.
  • Larger liposomes reduced fibril amount without significantly affecting lag time.
  • Increased liposome size led to shorter Aβ-(1-40) fibrils and more amorphous aggregates.

Conclusions:

  • Membrane curvature and increased water-accessible hydrophobic regions are crucial for Aβ monomer binding, concentration, and nucleation.
  • Amyloid fibrillation on membranes may compete with non-productive binding, forming amorphous aggregates.